Search - tctmd.com

Displaying 201 - 220 of 510

Sort: Relevancy | Date

News Industry News

Corindus Equips the World’s First Fully Robotic Catheterization Laboratory

May 07, 2019

News Industry News

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

May 06, 2019

News Features

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

Caitlin E. Cox

May 01, 2019

News Industry News

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

April 16, 2019

News Featured Fellow

Philipp Wiesner, MD

Yael L. Maxwell

April 01, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

News Conference News ISET 2019

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Caitlin E. Cox

February 07, 2019

News Conference News ISET 2019

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Caitlin E. Cox

January 29, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Opinion Fellow Talk

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Luai Tabaza, MD

January 10, 2019

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

News Daily News

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Caitlin E. Cox

January 04, 2019

News Daily News

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

Yael L. Maxwell

January 02, 2019

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

News Industry News

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

November 07, 2018

News Daily News

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Yael L. Maxwell

October 19, 2018

Advertisement

Corindus Equips the World’s First Fully Robotic Catheterization Laboratory

Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

Intact Vascular’s Tack Endovascular System® Receives FDA Approval

Philipp Wiesner, MD

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

PVI in Symptomatic Lower-Extremity PAD Offers Multiple Benefits, Even 2.5 Years Later

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Early CHIP-Trained Fellow in the United States Offers Insights: Sanjog Kalra, MD

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Tricuspid Valve Interventions in High-Risk Patients: Midterm Outcomes Encouraging in TriValve Registry

Cardiac Complications Are a Common Cause of Readmission Following Endovascular AAA Interventions

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Intact Vascular Announces Positive One-Year Data from the TOBA II Clinical Trial

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content